A novel ELISA-based crossmatch procedure to detect donor-specific anti-HLA antibodies responsible for corneal allograft rejections.
暂无分享,去创建一个
[1] U. Ott,et al. General insufficiency of the classical CDC-based crossmatch to detect donor-specific anti-HLA antibodies leading to invalid results under recipients' medical treatment or underlying diseases. , 2012, Histology and histopathology.
[2] T. Manzke,et al. Novel solid phase-based ELISA assays contribute to an improved detection of anti-HLA antibodies and to an increased reliability of pre- and post-transplant crossmatching , 2010, NDT plus.
[3] D. Larkin,et al. Immune Privilege of Corneal Allografts , 2010, Ocular immunology and inflammation.
[4] So young Lee,et al. Comparison of Antibody Monitoring System with Flow Cytometric Crossmatch Test in Renal Transplant Recipients with High Panel-Reactive Antibody , 2009, Nephron Clinical Practice.
[5] J. Forrester,et al. Cross Presentation of Antigen on MHC Class II via the Draining Lymph Node after Corneal Transplantation in Mice1 , 2008, The Journal of Immunology.
[6] B. Seliger,et al. Comparison of the established standard complement-dependent cytotoxicity and flow cytometric crossmatch assays with a novel ELISA-based HLA crossmatch procedure. , 2006, Histology and histopathology.
[7] E. Mayhew,et al. CD4+ T-Cell–Mediated Mechanisms of Corneal Allograft Rejection: Role of Fas-Induced Apoptosis , 2005, Transplantation.
[8] M. Dana,et al. Relevance of the Direct Pathway of Sensitization in Corneal Transplantation Is Dictated by the Graft Bed Microenvironment1 , 2004, The Journal of Immunology.
[9] D F P Larkin,et al. Corneal Transplantation: The Forgotten Graft , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[10] E. Mayhew,et al. Fate of MHC-matched corneal allografts in Th1-deficient hosts. , 2004, Investigative ophthalmology & visual science.
[11] G. Duncker,et al. Cross-matches on donor cadaver retinal pigment epithelial cells in corneal risk patients , 1996, Graefe's Archive for Clinical and Experimental Ophthalmology.
[12] G. Duncker,et al. DNA-based HLA class II postmortem typing: evaluation of different techniques for prospective corneal allografting , 1995, Graefe's Archive for Clinical and Experimental Ophthalmology.
[13] Robert W. Thompson,et al. Long-term graft survival after penetrating keratoplasty. , 2003, Ophthalmology.
[14] J. Lácha,et al. Clinical relevance of antibodies to HLA antigens undetectable by the standard complement-dependent cytotoxicity test , 2002, Transplant international : official journal of the European Society for Organ Transplantation.
[15] P. Wernet,et al. HLA class I and II matching improves prognosis in penetrating normal-risk keratoplasty. , 2003, Developments in ophthalmology.
[16] J. Niederkorn. Mechanisms of Corneal Graft Rejection: The Sixth Annual Thygeson Lecture, Presented at the Ocular Microbiology and Immunology Group Meeting, October 21, 2000 , 2001, Cornea.
[17] M. Dana,et al. Role of CD4+ and CD8+ T Cells in Allorecognition: Lessons from Corneal Transplantation1 , 2001, The Journal of Immunology.
[18] S. Sumitran-Holgersson,et al. HLA-specific alloantibodies and renal graft outcome. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[19] M. Dana,et al. Twenty-five–Year Panorama of Corneal Immunology: Emerging Concepts in the Immunopathogenesis of Microbial Keratitis, Peripheral Ulcerative Keratitis, and Corneal Transplant Rejection , 2000, Cornea.
[20] M. Dana,et al. Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts. , 1999, Transplantation proceedings.
[21] J. Streilein,et al. Fate of orthotopic corneal allografts in C57BL/6 mice. , 1998, Transplant immunology.
[22] M. Oz,et al. Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. , 1998, Circulation.
[23] P. Laughrea,et al. Role of presensitization and donor-recipient crossmatching in corneal graft outcome. , 1998, Cornea.
[24] M. Dana,et al. Loss and restoration of immune privilege in eyes with corneal neovascularization. , 1996, Investigative ophthalmology & visual science.
[25] B. Ksander,et al. Minor H, rather than MHC, alloantigens offer the greater barrier to successful orthotopic corneal transplantation in mice. , 1996, Transplant immunology.
[26] N. Fink,et al. The association of lymphocytotoxic antibodies with corneal allograft rejection in high risk patients. The Collaborative Corneal Transplantation Studies Research Group. , 1995, Transplantation.
[27] R. Howard,et al. The crossmatch in renal transplantation. Evaluation of flow cytometry as a replacement for standard cytotoxicity. , 1994, Transplantation.
[28] P. Laughrea,et al. Risk factors of corneal graft failure. , 1993, Ophthalmology.
[29] J. Streilein,et al. ORTHOTOPIC CORNEAL TRANSPLANTATION IN MICE—EVIDENCE THAT THE IMMUNOGENETIC RULES OF REJECTION DO NOT APPLY , 1992, Transplantation.
[30] P. Laughrea,et al. PRETRANSPLANT AND POSTTRANSPLANT ANTIBODIES IN HUMAN CORNEAL TRANSPLANTATION , 1992, Transplantation.
[31] P. Morris,et al. Hyperacute rejection of a renal allograft in the presence of anti-HLA-Cw5 antibody. , 1986, Transplantation.
[32] H. Perkins,et al. Flow cytometry analysis: A high technology cross-match technique facilitating transplantation , 1983 .
[33] P. Dellapelle,et al. Hyperacute rejection of HLA-AB-identical renal allografts associated with B lymphocyte and endothelial reactive antibodies. , 1982, Transplantation.
[34] J. Yada. [Graft rejection]. , 2020, Kangogaku zasshi.
[35] P. Terasaki,et al. Significance of the positive crossmatch test in kidney transplantation. , 1969, The New England journal of medicine.
[36] P. Terasaki,et al. Microdroplet Assay of Human Serum Cytotoxins , 1964, Nature.